E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 420.7 INR 2.41% Market Closed
Market Cap: 268.7B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Emcure Pharmaceuticals Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Emcure Pharmaceuticals Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Net Change in Cash
â‚ą2.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Change in Cash
-â‚ą2.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Change in Cash
-â‚ą1.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Change in Cash
â‚ą26.1B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Change in Cash
â‚ą6.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Net Change in Cash
â‚ą771.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Emcure Pharmaceuticals Ltd
Glance View

Market Cap
268.7B INR
Industry
Pharmaceuticals

Emcure Pharmaceuticals Ltd. emerged as a prominent player in the Indian pharmaceutical landscape, guided by a commitment to innovation and accessibility. Founded in 1981 by Satish Mehta, the company started as a small-scale manufacturer and has since evolved into a global pharmaceutical powerhouse. Emcure thrives on a multifaceted business model that encompasses the complete pharmaceutical value chain, from research and development to manufacturing and distribution. The company's success rests on its robust portfolio of generics, branded generics, and biopharmaceuticals, which cater to diverse therapeutic areas like cardiology, oncology, gynecology, and infectious diseases. The driving force behind Emcure's financial engine is its ability to balance volume and value. Through a network of state-of-the-art facilities, Emcure sustains a strong presence both domestically and internationally, with exports spanning over 70 countries. The firm capitalizes on economies of scale by leveraging its extensive production infrastructure, allowing it to offer high-quality medications at competitive prices. Furthermore, strategic collaborations and licensing agreements empower Emcure to penetrate new markets and broaden its product offerings. By continually expanding its pipeline and embracing cutting-edge technologies, Emcure not only secures its position in the competitive pharmaceutical industry but also reinforces its mission to deliver affordable healthcare solutions globally.

EMCURE Intrinsic Value
1 112.91 INR
Overvaluation 22%
Intrinsic Value
Price
E

See Also

What is Emcure Pharmaceuticals Ltd's Net Change in Cash?
Net Change in Cash
2.2B INR

Based on the financial report for Mar 31, 2024, Emcure Pharmaceuticals Ltd's Net Change in Cash amounts to 2.2B INR.

What is Emcure Pharmaceuticals Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
64%

Over the last year, the Net Change in Cash growth was 64%.

Back to Top